SNTISenti Biosciences
About Senti Biosciences
Senti Biosciences (NASDAQ:SNTI) is a biotechnology company focused on developing programmable biology therapies. Leveraging advances in synthetic biology, Senti Biosciences aims to engineer smarter medicines that can outmaneuver complex diseases, with a particular emphasis on oncology. Their projects include designing cell and gene therapies that promise more precise, potent, and durable treatments for various cancers. The company's objectives center around accelerating the discovery and development of these innovative therapies, striving to transform how chronic diseases are treated. Senti Biosciences is dedicated to pushing the boundaries of medicine to improve patient outcomes and quality of life.
What is SNTI known for?
Snapshot
Public US
Ownership
2016
Year founded
48
Employees
South San Francisco, United States
Head office
1 of 4
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
South San Francisco, US
Products and/or services of Senti Biosciences
- Development of next-generation CAR-NK cell therapies for treating solid tumors, utilizing synthetic biology to enhance efficiency and targeting.
- Design of programmable cell therapies for oncological applications, focusing on improved selectivity and reduced toxicity.
- Research into logic-gated CAR-T cell therapies to increase precision and minimize off-target effects in cancer treatment.
- Creation of a proprietary platform for the rapid design, testing, and production of synthetic gene circuits for use in cell and gene therapies.
- Advancement of biosensors and diagnostic tools for real-time monitoring of cellular functions and therapy outcomes.
- Exploration of novel delivery methods for gene therapies to improve access to difficult-to-reach tissues and tumors.
Senti Biosciences executive team
- Dr. Timothy K. Lu M.D., Ph.D.Co-Founder, CEO & Director
- Dr. Kanya Rajangam M.D., Ph.D.President, Head of Research & Development and Chief Medical Officer
- Dr. James J. Collins Ph.D.Scientific Co-Founder, Chairperson of Scientific Advisory Board & Independent Director
- Dr. Wilson Wong Ph.D.Scientific Co-Founder & Member of Scientific Advisory Board
- Mr. Jay CrossChief Financial Officer
- Mr. Faraz SiddiquiSenior Vice President of Technical Operations
- Mr. Robert H. Cutler J.D.Senior VP & Head of Legal Affairs
- Mr. Thomas P. ChungVice President of Strategic Finance & Corporate Development
- Ms. Dee Olomajeye DragonSenior VP of People & Culture Strategy & Head of Administrative Operations